Keyphrases
Netherlands
100%
Turkey
100%
Type 2 Diabetic Patients
100%
Drug Effects
100%
Relative Weight
100%
Preference Study
100%
Antidiabetic Drugs
66%
Gastrointestinal
50%
Hypoglycemic Events
50%
Type 2 Diabetes Mellitus (T2DM)
33%
Risk Reduction
33%
Adverse Drug Events
33%
Discrete Choice Experiment
33%
Patient Preference
33%
Cardiovascular Risk
33%
Cardiovascular Disease
16%
Clinical Practice
16%
Multinomial Logit Model
16%
Hemoglobin A1c (HbA1c)
16%
Weight Change
16%
Bladder Cancer
16%
Turkish Patients
16%
Interaction Factor
16%
Regulatory Decisions
16%
Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Drug Effect
100%
Oral Antidiabetic Agent
100%
Cardiovascular Disease
75%
Antidiabetic Agent
75%
Adverse Drug Reaction
50%
Maturity Onset Diabetes of the Young
50%
Patient Preference
50%
Cross Sectional Study
25%
Body Weight Change
25%
Hemoglobin A1c
25%
Bladder Cancer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Oral Antidiabetic Agent
100%
Cardiovascular Disease
75%
Antidiabetic Agent
75%
Adverse Drug Reaction
50%
Cross Sectional Study
25%
Hemoglobin A1c
25%
Bladder Cancer
25%
Biochemistry, Genetics and Molecular Biology
Drug Effect
100%
Patient Preference
66%
Cross Sectional Study
33%
Body Weight Change
33%
Immunology and Microbiology
Drug Effect
100%
Body Weight Change
33%